🧫

TLR expression in α-synuclein overexpressing mice

experiment Created: 2026-04-10 22:34:48 By: experiment_extractor Quality: 80% ✓ SciDEX ID: experiment-exp-546a7e07-4a45-4e78-b0f9-5
🧫 Experiment Protocol Animal Model
🧫 View Full Experiment Page →
Related Entities
TLR2, TLR4, SNCA
Metadata
experiment_typeanimal_model
protocolFlow cytometry and western blot analysis of blood and brain samples from transgenic mice
expected_outcomesPotential changes in TLR expression due to α-synuclein overexpression
success_criteriaDetectable changes in TLR2/TLR4 expression
sample_sizeNone
statistical_methodsNone
p_valueNone
effect_sizeNone
extracted_at2026-04-10T15:34:48.643959
source_pmid25522431
_origin{'type': 'internal', 'url': None, 'tracked_at': '2026-04-10T22:34:48.678422'}
Linked Artifacts (579)
derives_from📄Toll-like receptor expression in the blood and brain of pati100%
mentions📖SNCA-A53T Alpha-Synuclein Neurons80%
mentions📖SNCA-Overexpressing Dopaminergic Neurons80%
mentions📖SNCA A53T80%
mentions📖SNCA Gene Variants and Mutations80%
mentions📖SNCA — Alpha-Synuclein Gene Entity Page80%
mentions📖SNCA — Alpha-Synuclein80%
mentions📖SNCA→Alpha-synuclein→Aggregation→Lewy Bodies→Synucleinopathi80%
mentions📖SNCA→Alpha-synuclein→Parkinson's Disease Causal Chain80%
mentions📖snca-protein80%
mentions📖TLR2 — Toll-Like Receptor 280%
mentions📖TLR2 Protein — Toll-Like Receptor 280%
mentions📖entities-tlr480%
mentions📖TLR4 Gene80%
mentions📖Toll-Like Receptor 4 (TLR4)80%
mentions📖TLR4 Protein80%
mentions📖TLR4 Antagonists for Neurodegeneration80%
related📖SNCA-A53T Alpha-Synuclein Neurons72%
related📖SNCA-Overexpressing Dopaminergic Neurons72%
related📖SNCA A53T72%
related📖SNCA Gene Variants and Mutations72%
related📖SNCA — Alpha-Synuclein Gene Entity Page72%
related📖SNCA — Alpha-Synuclein72%
related📖SNCA→Alpha-synuclein→Aggregation→Lewy Bodies→Synucleinopathi72%
related📖SNCA→Alpha-synuclein→Parkinson's Disease Causal Chain72%
related📖snca-protein72%
related📖TLR2 — Toll-Like Receptor 272%
related📖TLR2 Protein — Toll-Like Receptor 272%
related📖entities-tlr472%
related📖TLR4 Gene72%
related📖Toll-Like Receptor 4 (TLR4)72%
related📖TLR4 Protein72%
related📖TLR4 Antagonists for Neurodegeneration72%
mentions📖TLR Signaling Pathway in Neurodegeneration70%
mentions📖TLR Signaling in Parkinson's Disease70%
related📖TLR Signaling Pathway in Neurodegeneration63%
related📖TLR Signaling in Parkinson's Disease63%
mentions📖Alzheimer's Disease vs Parkinson's Disease Compari60%
mentions📖ATP13A9 and Parkinson's Disease60%
mentions📖Caregiver Support and Palliative Care in Atypical [Parkinson60%
mentions📖Dementia with Lewy Bodies vs Parkinson's Disease Compar60%
mentions📖DLB, Parkinson's Disease, and Alzheimer's Disease:60%
mentions📖Investment Landscape: Parkinson's Disease60%
mentions📖PARK19 (DNAJC6-Related Parkinson's Disease)60%
mentions📖Parkinson's Disease60%
mentions📖Parkinson's Disease Dementia (PDD)60%
mentions📖Gut-First vs Brain-First Parkinson's Disease Trajectori60%
mentions📖Parkinson's Disease Genetic Variants60%
mentions📖Parkinson's Disease Subtypes60%
mentions📖Prodromal Parkinson's Disease60%
related📖Parkinson's Disease60%
related📖Alzheimer's Disease vs Parkinson's Disease Compari54%
related📖ATP13A9 and Parkinson's Disease54%
related📖Caregiver Support and Palliative Care in Atypical [Parkinson54%
related📖Dementia with Lewy Bodies vs Parkinson's Disease Compar54%
related📖DLB, Parkinson's Disease, and Alzheimer's Disease:54%
related📖Investment Landscape: Parkinson's Disease54%
related📖PARK19 (DNAJC6-Related Parkinson's Disease)54%
related📖Parkinson's Disease54%
related📖Parkinson's Disease Dementia (PDD)54%
related📖Gut-First vs Brain-First Parkinson's Disease Trajectori54%
related📖Parkinson's Disease Genetic Variants54%
related📖Parkinson's Disease Subtypes54%
related📖Prodromal Parkinson's Disease54%
mentions📖adpd-2026-precision-medicine-genetic-stratification50%
mentions📖Alpha-Synuclein Pathology50%
mentions📖Alpha-Synuclein Aggregation in PD50%
mentions📖Alpha-Synuclein Reduction Therapies for Neurodegenerative Di50%
mentions📖Epigenetic Therapies for Parkinson's Disease50%
mentions📖Alpha-Synuclein Overexpressing Neurons50%
mentions📖Epigenetic Dysregulation in Neurodegeneration50%
mentions📖RNA-Targeted Therapeutics Investment Synthesis50%
mentions📖MicroRNA Therapy for Parkinson's Disease50%
mentions📖Alpha-Synuclein Aggregation Pathway50%
mentions📖Synucleinopathies50%
mentions📖siRNA Therapy for Parkinson's Disease50%
mentions📖Alpha-Synuclein Propagation Mechanism50%
mentions📖Epigenetic Dysregulation Comparison -- AD/PD/ALS/FTD/HD50%
mentions📖msa-alpha-synuclein-glial-cytoplasmic-inclusions50%
mentions📖Synuclein Pathway in Parkinson's Disease50%
mentions📖CRISPR Gene Editing for Parkinson's Disease50%
mentions📖Epigenetic Dysregulation Hypothesis in Parkinson's Dise50%
mentions📖Synucleinopathy Mechanism50%
mentions📖ASO Therapy for Parkinson's Disease50%
mentions📖Epigenetics in Parkinson's Disease50%
mentions📖sporadic-familial-pd-comparison50%
mentions📖MSA Genetic Variants50%
mentions📖CRISPRi Epigenetic Silencing of SNCA for Parkinson's Di50%
mentions📖MSA Genetics and Risk Factors50%
mentions📖alpha-synuclein-seed-amplification50%
mentions📖Epigenetic Biomarkers in Neurodegenerative Diseases50%
mentions📖Striatum50%
mentions📖Aging Microglia50%
mentions📖Alpha-Synuclein Aggregation in Dopaminergic Neurons50%
mentions📖Disease-Associated Microglia50%
mentions📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas50%
mentions📖Iron-Laden Microglia50%
mentions📖Lipid-Loaded Microglia (Foam Cells)50%
mentions📖M1 Polarized Microglia50%
mentions📖Microglia in Nasu-Hakola Disease50%
mentions📖Photoreceptor Cells in Parkinson's Disease50%
mentions📖Primed Microglia50%
mentions📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di50%
mentions📖Spinal Cord Microglia50%
mentions📖Substantia Nigra Pars Compacta (SNc)50%
mentions📖Surveying Microglia50%
mentions📖coq10-qe350%
mentions📖Kenai RNDP-001 Dopaminergic Progenitor Cell Therapy for Park50%
mentions📖UPenn Observational Research Repository (NCT04715399)50%
mentions📖Dementia with Lewy Bodies (DLB)50%
mentions📖Familial vs Sporadic Neurodegenerative Disease Comparison50%
mentions📖Neurodegeneration50%
mentions📖Parkinson Disease50%
mentions📖rem-sleep-behavior-disorder50%
mentions📖Microglia in Neurodegeneration50%
mentions📖Nucleus Basalis of Meynert50%
mentions📖UB-31250%
mentions📖GLP-1 Agonist Responder Prediction Study — Precision Medicin50%
mentions📖Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&50%
mentions📖Gap Junction Dysfunction Hypothesis in Parkinson's Dise50%
mentions📖Therapeutic Hypothesis: TDP-43 and a-synuclein pathologies i50%
mentions📖Oligodendrocyte-Myelin Dysfunction Hypothesis in Parkinson&#50%
mentions📖Therapy Ideas50%
mentions📖MSA Combination Therapy50%
mentions📖Alpha-Synuclein Seeding Kinetics50%
mentions📖Calcium Homeostasis in Neurodegeneration50%
mentions📖Circular RNA Dysfunction in Neurodegeneration50%
mentions📖Dopamine Signaling Pathway50%
mentions📖Epigenetic Clocks in Brain Aging50%
mentions📖Epigenetic Dysregulation in Neurodegeneration50%
mentions📖ER Stress and Unfolded Protein Response in Parkinson's 50%
mentions📖Exosome-Mediated Pathological Protein Propagation50%
mentions📖GBA and Lysosomal Function in Parkinson's Disease50%
mentions📖gsk3-parkinsons50%
mentions📖Hippo Signaling Pathway in Parkinson's Disease50%
mentions📖Lactate Lactylation in Neurodegeneration50%
mentions📖Lewy Body Formation Pathway50%
mentions📖lewy-body-pathogenesis50%
mentions📖Liquid-Liquid Phase Separation50%
mentions📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&50%
mentions📖Mitochondria-Lysosome Contact Sites in Parkinson's Dise50%
mentions📖MLCS Research Methods in iPSC-Derived Dopaminergic Neurons50%
mentions📖msa-pathophysiology-disease-mechanisms50%
mentions📖MSA Treatment Approaches and Emerging Therapies50%
mentions📖Non-Dopaminergic Neurotransmitter Degeneration as Upstream D50%
mentions📖Parkinson's Disease Mechanisms50%
mentions📖Protein Aggregation Comparison in Neurodegeneration50%
mentions📖protein-trafficking-pathways50%
mentions📖RAB39B Endosomal-Lysosomal Dysfunction PD Causal Chain50%
mentions📖RNA-Targeted Therapies in Neurodegeneration50%
mentions📖Synaptic Dysfunction in Neurodegeneration50%
mentions📖CRISPR Gene Editing in Neurodegeneration50%
mentions📖Drug Target Landscape50%
mentions📖mRNA Therapy for Parkinson's Disease50%
mentions📖Synaptic Plasticity Therapeutics for Parkinson's Diseas50%
mentions📖Alpha-Synuclein Antisense Therapy for Parkinson's Disea50%
mentions📖All Pages50%
mentions📖Alpha-Synuclein - Biomarker50%
mentions📖Alpha-Synucleinopathy-Associated Neurons50%
mentions📖Oligodendrocytes in Multiple System Atrophy50%
mentions📖KP405 Phase 1 PD trial (NCT06189170)50%
mentions📖nct06365190-rtms-pd50%
mentions📖dementia-with-lewy-bodies50%
mentions📖Lewy Body Dementia50%
mentions📖Entities Overview50%
mentions📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation50%
mentions📖Ethnicity-Specific Genetic Architecture Hypothesis in Parkin50%
mentions📖Prion-Like Propagation of Proteinopathies — Template-Directe50%
mentions📖Post-Acute Viral Reservoir Hypothesis in Parkinson's Di50%
mentions📖Prion vs Tau/Alpha-Synuclein Propagation: Mechanistic Compar50%
mentions📖Circadian Entrainment Therapy for Neurodegeneration Preventi50%
mentions📖AAV Capsid Engineering for CNS-Targeted Neurodegeneration Th50%
mentions📖AAV-Delivered RNA Targeting Therapy for Neurodegeneration50%
mentions📖ESCRT-III Neuroprotection Therapy for Neurodegeneration50%
mentions📖Alpha-Synuclein Therapeutics: Investment Landscape Analysis50%
mentions📖ACLY Inhibition Rescues Alpha-Synuclein Autophagy50%
mentions📖Alpha-Synuclein ESCRT-III Inhibition Mechanism50%
mentions📖Alpha-Synuclein Exosomal Secretion50%
mentions📖Astrocyte Metabolic Enhancement Therapy for PD50%
mentions📖ATP13A2 Lysosomal Dysfunction Pathway in Parkinson's Di50%
mentions📖Axonal Transport Dysfunction Validation in Parkinson's 50%
mentions📖Extracellular Vesicles in Parkinson's Disease50%
mentions📖GBA1→GCase→Lysosome→PD Causal Chain50%
mentions📖JAK-STAT Signaling Pathway in Neurodegeneration50%
mentions📖MLCS Quantification Methods in Parkinson's Disease Rese50%
mentions📖mTOR Signaling in Parkinson's Disease50%
mentions📖Genetic Penetrance Factors in Parkinson's Disease50%
mentions📖Prime Editing for Neurodegenerative Diseases50%
mentions📖Protein Aggregation Seeds in Neurodegeneration50%
mentions📖Protein-Protein Interactions in Neurodegeneration50%
mentions📖RNA G-quadruplexes in Neurodegeneration50%
mentions📖Splice-Modulating Therapies for Neurodegeneration50%
mentions📖CRISPR Gene Editing for Neurodegenerative Diseases50%
mentions📖Digital Therapeutics for Parkinson's Disease50%
mentions📖AbbVie BRAIN Platform — Blood-Brain Barrier Delivery Technol50%
mentions📖Antisense Oligonucleotide Therapy for Neurodegeneration50%
mentions📖Antisense Oligonucleotide Therapy for Neurodegeneration50%
mentions📖Antisense Oligonucleotide Brain Delivery50%
mentions📖Autophagy Enhancers for PD50%
mentions📖bioactive-compound-autophagy-modulation50%
mentions📖CRISPR and Genome Editing Brain Delivery50%
mentions📖gba-gene-therapy50%
mentions📖Gene Silencing Therapy for Neurodegenerative Diseases50%
mentions📖Inotersen (Tegsedi) - Therapeutic Overview50%
mentions📖Intranasal Therapy for Parkinson's Disease50%
mentions📖Neurorestore Therapies for Parkinson's Disease50%
mentions📖NLRP3 Inflammasome Modulation for Parkinson's Disease50%
mentions📖PD Therapeutic Approaches Scorecard50%
mentions📖Section 107: CRISPR-Based Therapies in CBS/PSP50%
mentions📖Sirtuin Modulators for Parkinson's Disease50%
mentions📖Tissue Engineered Nigrostriatal Pathway for Parkinson's50%
mentions📖USP30 Deubiquitinase Inhibitors50%
mentions📖alpha-synuclein-LRRK2 Crosstalk50%
mentions📖MDS 2026 — Genetics and Biomarkers in Movement Disorders50%
mentions📖Dopamine Receptor Neurons50%
mentions📖atypical-parkinsonism-genetic-variants50%
mentions📖Genetic Risk Modifiers in DLB Phenotype50%
mentions📖Extracellular Vesicle-Mediated Synuclein Propagation Hypothe50%
mentions📖Mechanistic Proposal: Pathologic synergy: The pathologic agg50%
mentions📖Mitochondria-Lysosome Contact Site Dysfunction in Parkinson&50%
mentions📖Alpha-Synuclein (α-Synuclein)50%
mentions📖Alpha-Synuclein Propagation in Prodromal Parkinson's Di50%
mentions📖Membrane-Driven Alpha-Synuclein Nucleation50%
mentions📖MPTP Parkinson's Disease Model50%
mentions📖NCT04724941: Prodromal Alpha-Synuclein Screening50%
mentions📖PD Cure Roadmap50%
mentions📖RNA Splicing Defects in Neurodegeneration50%
mentions📖Buntanetap (PD-01)50%
mentions📖NAD+ Precursors (NMN/NR) for Parkinson's Disease50%
mentions📖saa-guided-alpha-synuclein-therapy50%
mentions📖substantia-nigra50%
mentions📖Alpha-Synuclein Expressing Neurons50%
mentions📖Alpha-Synuclein-Exposed Neurons50%
mentions📖alpha-synucleinopathies50%
mentions📖Novel Therapy Index50%
mentions📖RNA Therapeutics for Neurodegeneration Investment Landscape50%
mentions📖Alpha-Synuclein Oligomerization Pathways50%
mentions📖Alpha-Synuclein Propagation Pathway in Parkinson's Dise50%
mentions📖Epigenetic Dysregulation Comparison Across Neurodegenerative50%
mentions📖Epigenetic Regulation50%
mentions📖GBA Glucocerebrosidase Pathway in Parkinson's Disease50%
mentions📖GWAS Findings Hub: Alzheimer's and Parkinson's Dis50%
mentions📖Synaptic Vesicle Trafficking Pathway in Parkinson's Dis50%
mentions📖RNA Splicing in Neurodegeneration50%
mentions📖Denali Therapeutics50%
mentions📖AAV Vectors in Neurodegenerative Disease Gene Therapy50%
mentions📖crispr-gene-editing50%
mentions📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis50%
mentions📖diseases50%
mentions📖Alpha-Synucleinopathies Comparison Matrix50%
mentions📖Familial vs Sporadic Neurodegeneration Comparison50%
mentions📖Multiple System Atrophy50%
mentions📖Epigenetic Dysregulation Validation in Parkinson's Dise50%
mentions📖Mitochondria-Lysosome Contact Site (MLCS) Dysfunction Hypoth50%
mentions📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%
mentions📖Alpha-Synuclein Clearance Mechanisms50%
mentions📖Dementia with Lewy Bodies Mechanistic Pathway50%
mentions📖GWAS Findings Hub50%
mentions📖Membrane Trafficking Pathway Dysfunction in Neurodegeneratio50%
mentions📖msa-cure-roadmap50%
mentions📖oxidative-stress-comparison50%
mentions📖Alpha-Synuclein Immunotherapy50%
mentions📖Epigenetic Therapies for Parkinson's Disease50%
mentions📖RNA-Targeting Therapies for Neurodegenerative Diseases50%
mentions📖Parkinson Basal Ganglia Circuit50%
mentions📖Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson50%
mentions📖Lewy Body Formation50%
mentions📖MDS 2026 — PD Genetic and Molecular Mechanisms50%
mentions📖Protein Aggregation in Neurodegenerative Disease Comparison50%
mentions📖Alpha-Synuclein Aggregation Inhibitors50%
mentions📖CRISPR Gene Editing for Neurodegeneration50%
mentions📖GBA Gene Therapy for Parkinson's Disease50%
mentions📖Neurodegeneration Therapeutic Target Comparison Matrix50%
mentions📖Alpha-Synuclein Aggregation Pathway in Parkinson's Dise50%
mentions📖Alpha-Synuclein Transgenic Mouse Models50%
mentions📖epigenetics-neurodegeneration50%
mentions📖Multi-Ethnic Parkinson's Disease GWAS50%
mentions📖Alpha-Synuclein-Targeting Therapies50%
mentions📖Toll-Like Receptor Signaling in Neurodegeneration50%
mentions📖Innate Immune Pattern Recognition in 4R-Tauopathies50%
mentions📖Microglia50%
mentions📖Neuroinflammation in Alzheimer's Disease50%
mentions📖Neuroinflammation in Neurodegeneration50%
mentions📖pd-neuroinflammation-pathway50%
mentions📖HMGB1 Signaling in Neurodegeneration50%
mentions📖Neuroinflammation in PD50%
mentions📖Neuroinflammation and Microglia Pathway50%
mentions📖Neuroinflammation in Parkinson's Disease50%
mentions📖Neuroinflammation in Parkinson's Disease50%
mentions📖S100 Protein Signaling Pathway in Neurodegeneration50%
mentions📖Device Therapies Comparison for CBS/PSP50%
mentions📖S100 Protein (S100A8/A9/A12) Modulator Therapy for Neurodege50%
mentions📖Microglial Priming and Innate Immune Tolerance Therapy for N50%
mentions📖biomarkers50%
mentions📖Microglia in Chronic Neuroinflammation50%
mentions📖Spinal Cord Dorsal Horn Neurons50%
mentions📖GM-CSF Sargramostim Phase 2 (NCT04902703) - AD Immunotherapy50%
mentions📖AD vs PD Neuroinflammation Comparison Matrix50%
mentions📖amyloid-beta-cellular-uptake50%
mentions📖Biomarkers of Alzheimer Disease50%
mentions📖Biomarkers in Neurodegeneration50%
mentions📖Biomarkers for Parkinson's Disease50%
mentions📖Geniposide for Alzheimer's disease - immune biomarker t50%
mentions📖gut-brain-axis-tauopathy50%
mentions📖Microbiome-Gut-Brain Axis in Neurodegeneration50%
mentions📖Necroptosis Pathway in Neurodegeneration50%
mentions📖Neuroinflammation in [Parkinson's Disease](/diseases/pa50%
mentions📖NF-kB Signaling Pathway in Neurodegeneration50%
mentions📖NLRP3 Inflammasome Activation Pathway in Neurodegeneration50%
mentions📖ACI-35 Liposomal Vaccine50%
mentions📖Necroptotic Neurons50%
mentions📖Resistin-Responsive Neurons50%
mentions📖Psilocybin for Depression in MCI/AD (NCT04123314)50%
mentions📖Neuroimmune Response in 4R-Tauopathies: Cross-Disease Compar50%
mentions📖Innate Immune Signaling Pathways in Alzheimer's Disease50%
mentions📖Lactoferrin Neuroprotection in Neurodegenerative Diseases50%
mentions📖Gut Microbiome-Based Therapy for Neurodegeneration50%
mentions📖Low-Dose Naltrexone ALS Trial50%
mentions📖NF-κB Signaling Pathway in Neurodegeneration50%
mentions📖entities50%
mentions📖NF-κB Pathway Inhibition for Neurodegeneration50%
mentions📖Microglia Activation Mechanism50%
mentions📖Neuroinflammation Pathway50%
mentions📖Immune Drug Repurposing for Advanced Parkinson's Diseas50%
mentions📖neuroinflammation50%
mentions📖Neuroinflammation Comparison — AD/PD/ALS/FTD/HD50%
mentions📖Parabacteroides goldsteinii Mitigation of Parkinsonism in LR50%
mentions📖Alpha-Synuclein Oligomers - Biomarker44%
mentions📖Amyloid Beta 40 (Aβ40) - Biomarker44%
mentions📖Biomarkers for Multiple System Atrophy44%
mentions📖Parkinson's Disease Biomarkers44%
mentions📖Phosphorylated Alpha-Synuclein (pSer129) - Biomarker44%
mentions📖Total Tau (t-Tau) - Biomarker44%
mentions📖Amyloid-Beta Metabolism in Cortical Neurons44%
mentions📖Amyloid-Beta-Exposed Neurons44%
mentions📖Amyloid-Beta-Exposed Neurons44%
mentions📖Autonomic Neurons in Multiple System Atrophy44%
mentions📖CA2 Pyramidal Neurons44%
mentions📖Cerebellar Neurons in Multiple System Atrophy44%
mentions📖Dopaminergic Neurons44%
mentions📖Dopaminergic Neurons (SNpc)44%
mentions📖dopaminergic-vta-pd44%
mentions📖Enteric Neurons with Alpha-Synuclein Pathology44%
mentions📖Globus Pallidus Internus in Parkinsons Disease44%
mentions📖Taste Receptor Cells in Neurodegeneration44%
mentions📖Melanocytes in Parkinson Disease44%
mentions📖Microglia in Batten Disease44%
mentions📖Microglia in Parkinson Disease44%
mentions📖Microglia in Rasmussen Encephalitis44%
mentions📖Microglia State Index44%
mentions📖Microglia in Synapse Pruning44%
mentions📖Mitochondrial Dysfunction Dopaminergic Neurons44%
mentions📖Microglia in Parkinson's Disease Substantia Nigra44%
mentions📖Nigrostriatal Dopamine Terminals in Parkinson's Disease44%
mentions📖Raphe Nuclei in Mood Regulation and Neurodegeneration44%
mentions📖Rotenone-Exposed Dopaminergic Neurons44%
mentions📖Substantia Nigra Pars Compacta Dopamine Neurons in Parkinson44%
mentions📖Synucleinopathy Neurons44%
mentions📖Tau Pathology Astrocytes (TPA)44%
mentions📖Ventral Tegmental Area Dopaminergic Neurons44%
mentions📖Vulnerable Dopaminergic Neurons in Parkinson's Disease44%
mentions📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial44%
mentions📖[18F]ACI-15916 PET Alpha-Synucleinopathies Imaging Trial44%
mentions📖Apocynin for Parkinson's Disease44%
mentions📖Bacillus Subtilis for Parkinson Disease (NCT06487975)44%
mentions📖biib122-luma-lrrk2-inhibitor-pd44%
mentions📖BLAAC PD - Black and African Americans Connections to PD (NC44%
mentions📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par44%
mentions📖Intranasal Insulin and Glutathione for PD (NOSE-PD)44%
mentions📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin44%
mentions📖nct05266417-nose-pd44%
mentions📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin44%
mentions📖Dyadic Mindfulness for PD Carers (NCT06821230)44%
mentions📖Amino Acid Supplement in Parkinson's Disease (NCT06954644%
mentions📖Prasinezumab Phase 3 Parkinson's Disease Trial (NCT071744%
mentions📖Vibrotactile Stimulation Walking Speed PD Trial44%
mentions📖NouvNeu001 Cell Therapy for Parkinson's Disease44%
mentions📖PDE4 Inhibitor PD Trial44%
mentions📖Retigabine PD Trial44%
mentions📖Valacyclovir for HSV-1-Positive Parkinson's Disease44%
mentions📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x44%
mentions📖datasets44%
mentions📖AMP-PD: Accelerating Medicines Partnership: Parkinson's44%
mentions📖Disease Classification & Relationships44%
mentions📖LRRK2 G2019S44%
mentions📖MDS 2026 — Genetic Parkinson's Disease Research Summary44%
mentions📖Mitochondrial Diseases and Neurodegeneration Comparison Matr44%
mentions📖Multiple System Atrophy44%
mentions📖Pure Autonomic Failure44%
mentions📖Amyloid PET Imaging44%
mentions📖Amyloid-Related Imaging Abnormalities (ARIA)44%
mentions📖DNA Methylation44%
mentions📖Tau Oligomers44%
mentions📖Tau PET Imaging in Neurodegenerative Disease44%
mentions📖MDS 2026: Neuroprotection and Neurorestorative Strategies fo44%
mentions📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back44%
mentions📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio44%
mentions📖Combination Therapy Sequencing in Parkinson's Disease44%
mentions📖Tau Co-Pathology in DLB Clinical Heterogeneity44%
mentions📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 44%
mentions📖Validation: Membrane-Nucleation in iPSC Neurons44%
mentions📖Experiment: Multi-Ethnic PD GWAS44%
mentions📖Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#44%
mentions📖Parkinson's Disease Subtype Classification — Precision 44%
mentions📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&44%
mentions📖Tau ASO Therapy44%
mentions📖Cellular Senescence Hypothesis in Parkinson's Disease44%
mentions📖Glymphatic-Circadian Axis Dysfunction Hypothesis in Parkinso44%
mentions📖Peroxisomal Dysfunction Hypothesis in Parkinson's Disea44%
mentions📖Purinergic Signaling Dysfunction Hypothesis in Parkinson44%
mentions📖Microglia-Targeted Nanoparticles for CNS Delivery44%
mentions📖DLB Knowledge Gaps44%
mentions📖Tau-Seed Interception Using Conformational-Selective Extrace44%
mentions📖AAV Serotype CNS Delivery Optimization Therapy44%
mentions📖Microglia-State Editing via TREM2-LXR Pulse Program44%
mentions📖mRNA-Encoded Intrabody for Alpha-Synuclein Clearance44%
mentions📖MSA Combination Therapy44%
mentions📖ESCRT-III Inhibition by Alpha-Synuclein44%
mentions📖Prodromal Resilience Package for Genetically High-Risk Cohor44%
mentions📖Amyloid Therapeutics: Investment Landscape Analysis44%
mentions📖Tau Proteostasis and Clearance Across 4R-Tauopathies44%
mentions📖Alpha-Synuclein Propagation Mechanisms44%
mentions📖Amyloid Conformational Strains44%
mentions📖Amyloid Oligomers in Neurodegeneration44%
mentions📖Amyloid-Tau Synergistic Interaction Hypothesis in Alzheimer&44%
mentions📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration44%
mentions📖Autophagy-Lysosome Pathway in Neurodegeneration44%
mentions📖Calcium Dysregulation in Neurodegenerative Diseases44%
mentions📖CBS/PSP Genetic Architecture44%
mentions📖Cerebellar Degeneration Pathway44%
mentions📖Convergent Pathways in Neurodegeneration44%
mentions📖Cross-Disease Mechanistic Convergence Investment Ranking44%
mentions📖Disease Mechanism Taxonomy44%
mentions📖DNA Methylation in Neurodegeneration44%
mentions📖Dopamine Pathway44%
mentions📖Dopaminergic Neurodegeneration44%
mentions📖environmental-risk-factors44%
mentions📖GBA Therapy in Parkinson's Disease44%
mentions📖glial-cytoplasmic-inclusions-msa44%
mentions📖Gut-First vs Brain-First Alpha-Synuclein Propagation in Park44%
mentions📖Gut Microbiome-Derived Lipids and Alpha-Synuclein Aggregatio44%
mentions📖Kinase Targeting for Neurodegenerative Diseases44%
mentions📖lncRNA Signaling in Neurodegeneration44%
mentions📖Macroautophagy Dysfunction Validation Framework in Parkinson44%
mentions📖Metal Ion-Synuclein-Mitochondria (MISM) Axis in Parkinson&#x44%
mentions📖MicroRNA Dysfunction in Neurodegeneration44%
mentions📖miRNA Regulatory Pathway in Neurodegeneration44%
mentions📖MSA Animal Models and Preclinical Research44%
mentions📖Mitochondrial DNA Mutations in Neurodegeneration44%
mentions📖Multi-Omics Integration in Neurodegeneration44%
mentions📖Multiple System Atrophy Mechanistic Pathway44%
mentions📖Network Pharmacology for Neurodegeneration44%
mentions📖Neuroresilience Mechanisms and Evidence44%
mentions📖NRF2 Oxidative Stress Pathway44%
mentions📖PD Failed Approaches Autopsy44%
mentions📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031044%
mentions📖Polygenic Risk Scores in Neurodegenerative Disease44%
mentions📖Precision Medicine in Neurodegeneration44%
mentions📖Prion-Like Spread in Neurodegeneration44%
mentions📖Selective Neuronal Vulnerability44%
mentions📖Selective Vulnerability of Substantia Nigra Dopaminergic Neu44%
mentions📖Therapeutic Development Failure Mode Analysis Synthesis44%
mentions📖Transcription Regulation in Neurodegenerative Diseases44%
mentions📖A30P Alpha-Synuclein Transgenic Mouse Model44%
mentions📖Tau Consortium44%
mentions📖What to Work On — NeuroWiki Decision Guide44%
mentions📖AI-Powered Movement Analysis for Parkinson's Disease44%
mentions📖AlphaFold for Neurodegenerative Diseases44%
mentions📖Digital Biomarker Platforms for Parkinson's Disease44%
mentions📖Wearable Sensors for Parkinson's Disease44%
mentions📖AD/PD Therapeutic Target Comparison Matrix44%
mentions📖Adenosine A2A Receptor Antagonists44%
mentions📖Antisense Oligonucleotide (ASO) Therapies for Neurodegenerat44%
mentions📖Antisense Oligonucleotide Therapy44%
mentions📖Antisense Oligonucleotides for Neurodegeneration44%
mentions📖ASO-Tau Reduction44%
mentions📖circRNA Dysfunction Restoration Therapy44%
mentions📖Combination Therapy Approaches in Neurodegenerative Disease44%
mentions📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D44%
mentions📖Gene Editing for Neurodegenerative Diseases44%
mentions📖Levodopa-Carbidopa Intestinal Gel (LCIG)44%
mentions📖Retinoid Pathway Modulator Therapy for Neurodegenerative Dis44%
mentions📖RNA Targeting Therapy for Neurodegeneration44%
mentions📖Therapeutic Targets Index44%
mentions📖Microglia in Alzheimer's Disease44%
mentions📖Neuroinflammation Microglia44%
mentions📖NLRP3 Inflammasome Hypothesis in Parkinson's Disease44%
mentions📖Cross-Disease Neuroinflammation Mechanisms44%
mentions📖Inflammaging in Neurodegeneration44%
mentions📖Microglia-Neuron Metabolic Cross-Talk in Neurodegeneration44%
mentions📖Neuroinflammation in Alzheimer's Disease44%
mentions📖Neuroinflammation in Alzheimer and Parkinson Disease44%
mentions📖neuroinflammation-ad-pd-als44%
mentions📖Neuroinflammation in Alzheimer's Disease44%
mentions📖Neuroinflammation Across AD, PD, ALS, FTD, and HD44%
mentions📖High Mobility Group Box 1 (HMGB1) - Biomarker44%
mentions📖Neurofilament Light Chain (NfL) in Blood - Biomarker44%
mentions📖Neurofilament Light Chain (NfL) - Biomarker44%
mentions📖Brain Region Connectivity Index44%
mentions📖Brain Region Disease Involvement44%
mentions📖Brain Region Vulnerability Map44%
mentions📖Brain Endothelial Cells44%
mentions📖Brain Organoid Neurons44%
mentions📖Brain Pericytes in Neurodegeneration44%
mentions📖Brain Pericytes in Neurodegeneration44%
mentions📖Brain Vascular Endothelial Cells44%
mentions📖Brain Capillary Endothelial Cells44%
mentions📖Cerebellar Granule Cells in Neurodegenerative Disease44%
mentions📖Cerebellar Neurons in Creutzfeldt-Jakob Disease44%
mentions📖Cerebellar Purkinje Cells44%
mentions📖Brain Endothelial Cells44%
mentions📖Brain Endothelial Cells in Neurodegeneration44%
mentions📖Brain Ependymal Cells44%
mentions📖Neuroprotective Microglia44%
mentions📖Nigral Microglia in Parkinson's Disease44%
mentions📖nlrp3-inflammasome-activated-microglia44%
mentions📖Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Di44%
mentions📖Pedunculopontine Nucleus Neurons in Lewy Body Disease44%
mentions📖Brain Pericytes44%
mentions📖Spinal Cord Interneurons in Motor Neuron Disease44%
mentions📖Brain Venous Endothelial Cells44%
mentions📖Brain Activity During Complex Walking in Atypical Parkinsoni44%
mentions📖Atypical Parkinsonism44%
mentions📖NfL-Guided Neuroprotection Threshold44%
mentions📖IRAK4 Kinase Modulation Therapy for Neurodegeneration44%
mentions📖Brain-Computer Interface Investment Landscape44%
mentions📖Brain Region Vulnerability in 4R-Tauopathies44%
mentions📖Amyloid-beta Cellular Uptake Pathway44%
mentions📖brain-age-gap-amyloid-ad44%
mentions📖Brain Endothelial Cell Dysfunction in Neurodegeneration44%
mentions📖Brain Insulin Signaling Pathway44%
mentions📖Brain Region Therapeutic Targeting Index44%
mentions📖Brain Reserve in Neurodegeneration44%
mentions📖Brain Volume Changes in Early Alzheimer's Disease44%
mentions📖CBS Microglial Neuroimmune Axis44%
mentions📖Oxidative Stress in Corticobasal Syndrome44%
mentions📖Cerebrovascular Disease in Neurodegeneration44%
mentions📖cross-disease44%
mentions📖Glial-Neuron Crosstalk in Parkinson's Disease44%
mentions📖Gut-Brain Axis in Neurodegeneration44%
mentions📖Gut-Microbiome-Neurodegeneration Axis44%
mentions📖Hydrogen Sulfide Signaling Pathway in Neurodegeneration44%
mentions📖Innate Immune Response in Neurodegeneration44%
mentions📖IVNS1ABP Mutation: Progeria-Like Disease with Neurological D44%
mentions📖JNK/p38 MAPK Signaling Pathway in Neurodegeneration44%
mentions📖Lipid Raft Dysfunction in Neurodegeneration44%
mentions📖LRRK2 Signaling Pathway in Parkinson's Disease44%
mentions📖Necroptosis in Neurodegeneration44%
mentions📖NF-κB Signaling in Neuroinflammation44%
mentions📖nfkb-neurodegeneration44%
mentions📖Brain-Computer Interface Technologies44%
mentions📖Brain-Computer Interface for Amyotrophic Lateral Sclerosis44%
mentions📖Brain-Computer Interface for Corticobasal Degeneration44%
mentions📖Brain-Computer Interface for Frontotemporal Dementia44%
mentions📖Brain-Computer Interface for Huntington's Disease44%
mentions📖Brain-Computer Interface Technologies44%
mentions📖Brain-Computer Interface for Lewy Body Dementia44%
mentions📖Brain-Computer Interface for Multiple System Atrophy44%
mentions📖Brain-Computer Interface for Normal Pressure Hydrocephalus44%
mentions📖Brain-Computer Interface for Parkinson's Disease44%
mentions📖Brain-Computer Interface for Progressive Supranuclear Palsy44%
mentions📖Brain-Computer Interface Technology Landscape44%
mentions📖Brain-Computer Interface for Vascular Dementia44%
mentions📖Brain-Computer Interfaces44%
mentions📖Brain Knowledge Platform44%
mentions📖Brain Organoid-Silicon Interface Technology44%
mentions📖Brain Organoids44%
mentions📖Brain Organoids for Neurodegeneration Research44%
mentions📖Brain Shuttle Technologies: BBB Delivery Platforms44%
mentions📖Brain Shuttle Technologies44%
mentions📖Brain-to-Brain Interface Technology44%
mentions📖Brain Waste Clearance and CSF Dynamics Therapies44%
mentions📖Akkermansia muciniphila in CNS Disorders44%
mentions📖Brain Drug Delivery Challenges Overview44%
mentions📖nadph-oxidase-inhibitors44%
mentions📖NLRP3 Inhibitors for Neurodegeneration44%
mentions📖Pyroptosis Inhibition Therapy44%
mentions📖Section 101: Microbiome-Gut-Brain Axis in CBS/PSP44%
mentions📖TLR7/8/9 Antagonists for Neurodegeneration44%